New drug for schizophrenia has experts excited

Experts expressed enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors. “This drug takes the first new approach to schizophrenia treatment